Glostrup Apotek
Glostrup Apotek is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
BONG: Reducing severe Breathlessness with Dronabinol in the severe and very severe chronic obstructive pulmonary disease patient group
Sponsor Lillebaelt Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
Efficacy and safety of cannabidiol for pain relief of patients with end-stage metastatic castration resistant prostate cancer - a randomised double-blinded placebo-controlled phase II trial (ProCan)
Sponsor Regionshospital Nordjylland
- Start (EU)
- Latest update
- Estimated end
- Not reported
Effect of methylphenidate on cancer-related fatigue in patients treated for a brain tumor during childhood or adolescence: Protocol for a randomized, double-blind, placebo-controlled crossover trial - the EMBRAIN trial
Sponsor Odense University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
Topical tacrolimus for the amelioration of breast cancer-related lymphedema: a randomized, double-blind, placebo-controlled phase II/III trial
Sponsor Odense University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Glostrup Apotek?
The 2026-10-09 snapshot links Glostrup Apotek to 4 distinct CTIS trials. Recorded services include Medicinal product management. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Glostrup Apotek?
The most frequently recorded therapeutic areas are Respiratory, Solid Tumor Oncology, Urology. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Glostrup Apotek conducted?
The linked trials record locations in 1 country, including Denmark. These are trial locations, not confirmed office locations or countries where Glostrup Apotek delivered services.
What can this page tell me about Glostrup Apotek's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Glostrup Apotek. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Glostrup Apotek